Clinical trials: COVID19 Patients
Cancer
Booster Dose Trial
The goal of this study is to assess the safety and effectiveness of COVID vaccine booster doses in patients with cancer who have not developed an antibody after the U.S.
- Trial name
- NCT05016622
- Testing
- BNT162b2 vaccine
- Where
- United States
- Volunteers
- 106 people
- Sponsor
- Montefiore Medical Center
COVID-19 Respiratory Infection
CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients
T-cell exhaustion may limit long-term immunity in COVID-19 patients. T cells can lose their ability to fight viruses and tumors when they have prolonged exposure to these enemies.
- Trial name
- NCT04990557
- Testing
- PD-1 and ACE2 Knockout T Cells
- Volunteers
- 16 people
- Sponsor
- Mahmoud Ramadan mohamed Elkazzaz
Coronavirus Infection
Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy
This study will assess the prevalence and incidence of COVID-19 infection in patients with chronic plaque psoriasis on immunosuppressant therapy.
- Trial name
- NCT04324866
- Testing
- Nasopharyngeal swab
- Volunteers
- 300 people
- Sponsor
- Universita di Verona
Covid19
COVID-19 Infection in Cancer Pantients
It's an obsevational retrospective/prospective study. Analyzing the evolution of COVID 19 infection in cancer patients can provide interesting information in the management of these patients.
- Trial name
- COICA (NCT04569292)
- Testing
- No intervention on patients
- Where
- Italy
- Volunteers
- 150 people
- Sponsor
- Ospedale Andrea Tortora di Pagani
Viral Pneumonia, Sepsis
Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis
This prospective observational pilot study investigates circulatory coherence in patients with COVID and non-COVID sepsis by comparison of microcirculation, endothelial glycocalyx, and clinical course
- Trial name
- NCT04644302
- Testing
- microcirculation recording
- Where
- Czechia
- Volunteers
- 28 people
- Sponsor
- University Hospital Hradec Kralove
ARDS, Human, Extracorporeal Membrane Oxygenation
Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
Prone position ventilation was used 220 times in 44 out of 68 patients with severe COVID-19 induced ARDS treated with VV-ECMO. PPV treated patients did not benefit from PPV and the incidence of PPV related adverse events was high
- Conditions
- ARDS, Human, Extracorporeal Membrane Oxygenation, COVID-19 Acute Respiratory Distress Syndrome, Prone Position
- Trial name
- NCT05693051
- Testing
- Prone position ventilation
- Where
- 2 sites in Denmark
- Volunteers
- 68 people
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Covid19, Rheumatic Fever
Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients
Recent studies have highlighted the consequences of COVID-19 pandemic and social distancing on mental health of individuals. The aim of this study is to evaluate those consequences within a sample of inflammatory chronic…
- Conditions
- Covid19, Rheumatic Fever, Mental Disorder
- Trial name
- EMOPTION (NCT04798053)
- Testing
- Questionnaire, blood sample and salivary sample
- Where
- 7 sites in France
- Volunteers
- 259 people
- Sponsor
- University Hospital, Bordeaux
Diarrhea, COVID-19
Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)
The Center for Disease Control (CDC) and World Health Organization (WHO) have deemed the COVID-19 virus a global pandemic of unprecedented severity in modern times.
- Trial name
- SABER-C (NCT04811339)
- Testing
- Bismuth Subsalicylate 262 milligram (mg) Oral Tablet, Chewable
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- University of Cincinnati
COVID-19
Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia
The main objective of our study is to determine if treatment with sirolimus can improve clinical outcomes in hospitalized patients with COVID-19.
- Trial name
- SCOPE (NCT04341675)
- Testing
- Sirolimus
- Where
- 2 sites in United States
- Volunteers
- 32 people
- Sponsor
- University of Cincinnati
Volume Responsiveness
Correlation of Carotid Flow Time and Cardiac Output.
Assessment of common carotid artery flow is more easily done and can be taught more broadly than transthoracic echocardiography, providing a greater number of clinicians a tool to assess volume responsiveness.
- Trial name
- NCT04614701
- Testing
- Carotid Artery Ultrasound Measure
- Where
- Canada
- Sponsor
- St. Boniface Hospital
Covid-19
Hydrogen Therapy in Patients With Moderate Covid-19
SARS-CoV-2 is the agent responsible for a new infectious respiratory disease called Covid-19 (for CoronaVirus Disease 2019) which is mainly characterized by potentially severe and fatal lung damage.
- Trial name
- H2Covid (NCT04633980)
- Testing
- Mixture 3,6% H2 in N2 (96.4%)
- Where
- France
- Volunteers
- 12 people
- Sponsor
- University Hospital, Grenoble
COVID
COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador
In December 2019, an outbreak of pneumonia of initially unknown cause was detected in Wuhan (Hubei, China), and it was quickly determined that it was caused by a new coronavirus, that is, the SARS-CoV- 2 virus, causing the…
- Trial name
- NCT04362969
- Where
- Ecuador
- Volunteers
- 300 people
- Sponsor
- Hospital San Carlos, Madrid
Chronic Liver Disease
Antibody Response to COVID-19 Vaccines in Liver Disease Patients
Currently the Pfizer-Biontech (mRNA), Sinovac (inactivated virus) and Astrazeneca-Oxford (adenovirus-vector) COVID-19 vaccines are available for vaccination in HK.
- Trial name
- NCT04775069
- Testing
- BNT162b2, CoronaVac, AZD1222
- Where
- Hong Kong
- Volunteers
- 232 people
- Sponsor
- Humanity & Health Medical Group Limited
Covid19, Hematologic Malignancy
Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that was first reported in December 2019 in Wuhan, China. Infection with this new coronavirus called SARS-CoV-2 can lead to fatal pneumonia associated with…
- Conditions
- Covid19, Hematologic Malignancy, Vaccine Response Impaired
- Trial name
- HEMVACO (NCT04852796)
- Testing
- Patients with hemopathy
- Where
- France
- Volunteers
- 1,000 people
- Sponsor
- Centre Hospitalier de Cornouaille
Mechanical Ventilation, Covid19
Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy
Background: Invasive mechanical ventilation (IMV) in COVID-19 patients has been associated with a high mortality rate. In this context, the utility of tracheostomy has been questioned in this group of ill patients.
- Conditions
- Mechanical Ventilation, Covid19, Tracheostomy
- Trial name
- NCT04642703
- Where
- Chile
- Volunteers
- 100 people
- Sponsor
- University of Chile
Critical Illness, Covid19
Psychological Impact of COVID-19 Outbreak on Caregivers
Based on the experience of previous pandemics, countries reacted by applying different upgrade strategies to prevent or delay the widespread of the disease.
- Conditions
- Critical Illness, Covid19, Stress Disorders, Post-Traumatic
- Trial name
- PSY-CO-ICU (NCT04511780)
- Testing
- questionnaire filling
- Where
- 51 sites in France
- Volunteers
- 701 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
Covid19, Ventilators, Mechanical
Efficacy of FES Cycling After a Severe Form of COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the coronavirus disease 2019 (COVID-19) affect at late march 2021 more than 127 millions of persons worldwide (including more than 4.5 millions in France…
- Conditions
- Covid19, Ventilators, Mechanical, Respiratory Distress Syndrome
- Trial name
- FESrehabCoV (NCT04841746)
- Testing
- Physical therapy that include a standardized cycling training with functional electrical stimulation, Physical therapy that include a standardized cycling training with no additional functional electrical stimulation
- Where
- France
- Volunteers
- 22 people
- Sponsor
- Hospices Civils de Lyon
SARS-CoV-2 Infection
Halodine Nasal Antiseptic in Patients With COVID-19
Povidone iodine (PVP-I) is a well-known broad spectrum, resistance free antimicrobial agent that has a long history of safe and effective use.
- Trial name
- NCT04517188
- Testing
- Povidone-Iodine Solution 1.25% w/w [0.125% available iodine] USP
- Volunteers
- 40 people
- Sponsor
- Halodine LLC
COVID-19, SARS-CoV Infection
Glycine Supplement for Severe COVID-19
This study will explore whether a daily supplement of glycine, a substance that has antiinflammatory, cytoprotective, and endothelium-protecting effects, can improve mortality, as well as clinical and biochemical parameters, in…
- Conditions
- COVID-19, SARS-CoV Infection, SARS (Severe Acute Respiratory Syndrome), SARS Pneumonia
- Trial name
- NCT04443673
- Testing
- Glycine
- Where
- Mexico
- Volunteers
- 59 people
- Sponsor
- Instituto Nacional de Enfermedades Respiratorias
Post-Acute COVID-19 Syndrome, Post-Acute COVID-19
Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
The PRECISION is a proof-of-concept, phase II randomized clinical trial aiming to evaluate the efficacy and safety of anakinra in patients with Post-Acute COVID Syndrome (PACS) of the pro-inflammatory respiratory phenotype.
- Conditions
- Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, Long COVID
- Trial name
- PRECISION (NCT05926505)
- Testing
- Anakinra 149 MG/ML Prefilled Syringe [Kineret]
- Where
- 24 sites in Germany, Greece and 2 more
- Volunteers
- 182 people
- Sponsor
- Hellenic Institute for the Study of Sepsis
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.